Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F J Wackers

Showing results (81-90 of 159) with videos related to

Pageof 16
Sort By:
Circulation|December 1, 1981
Pathophysiologic correlates of right ventricular thallium-201 uptake in a canine modelF J Wackers, J W Klay, H Laks, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1993
Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocolD Jain, F J Wackers, J Mattera, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1990
Serial changes in myocardial perfusion using tomographic technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging following reperfusion therapy of myocardial infarctionP A Pellikka, T Behrenbeck, M S Verani, et al.
Cancer Investigation|April 1, 1999
Assessment of cardiac and pulmonary function in adult patients with Hodgkin's disease treated with ABVD or MOPP/ABVD plus adjuvant low-dose mediastinal irradiationE Salloum, L T Tanoue, F J Wackers, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|November 1, 1994
Reduced variability of interpretation and improved image quality with a technetium 99m myocardial perfusion agent: comparison of thallium 201 and technetium 99m-labeled tetrofosminR C Hendel, M A Parker, F J Wackers, et al.
Journal of the American College of Cardiology|October 1, 1988
Peak filling rate normalized to mitral stroke volume: a new Doppler echocardiographic filling index validated by radionuclide angiographic techniquesL K Bowman, F A Lee, C C Jaffe, et al.
Anesthesiology|November 1, 1995
Preoperative dipyridamole thallium imaging and ambulatory electrocardiographic monitoring as a predictor of perioperative cardiac events and long-term outcomeL A Fleisher, S H Rosenbaum, A H Nelson, et al.
Journal of the American College of Cardiology|July 1, 1988
Electrophysiologic effects of thrombolytic therapy in patients with a transmural anterior myocardial infarction complicated by left ventricular aneurysm formationP T Sager, R A Perlmutter, L E Rosenfeld, et al.
The American Journal of Cardiology|September 1, 1978
Prevalence of right ventricular involvement in inferior wall infarction assessed with myocardial imaging with thallium-201 and technetium-99m pyrophosphateF J Wackers, K I Lie, E B Sokole, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 20, 1998
Nonperfusion applications in nuclear cardiology: report of a task force of the American Society of Nuclear CardiologyE G DePuey, S Port, F J Wackers, et al.
Pageof 16

Showing results (81-90 of 159) with videos related to

Sort By:
Pageof 16
Circulation|December 1, 1981
Pathophysiologic correlates of right ventricular thallium-201 uptake in a canine modelF J Wackers, J W Klay, H Laks, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1993
Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocolD Jain, F J Wackers, J Mattera, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1990
Serial changes in myocardial perfusion using tomographic technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging following reperfusion therapy of myocardial infarctionP A Pellikka, T Behrenbeck, M S Verani, et al.
Cancer Investigation|April 1, 1999
Assessment of cardiac and pulmonary function in adult patients with Hodgkin's disease treated with ABVD or MOPP/ABVD plus adjuvant low-dose mediastinal irradiationE Salloum, L T Tanoue, F J Wackers, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|November 1, 1994
Reduced variability of interpretation and improved image quality with a technetium 99m myocardial perfusion agent: comparison of thallium 201 and technetium 99m-labeled tetrofosminR C Hendel, M A Parker, F J Wackers, et al.
Journal of the American College of Cardiology|October 1, 1988
Peak filling rate normalized to mitral stroke volume: a new Doppler echocardiographic filling index validated by radionuclide angiographic techniquesL K Bowman, F A Lee, C C Jaffe, et al.
Anesthesiology|November 1, 1995
Preoperative dipyridamole thallium imaging and ambulatory electrocardiographic monitoring as a predictor of perioperative cardiac events and long-term outcomeL A Fleisher, S H Rosenbaum, A H Nelson, et al.
Journal of the American College of Cardiology|July 1, 1988
Electrophysiologic effects of thrombolytic therapy in patients with a transmural anterior myocardial infarction complicated by left ventricular aneurysm formationP T Sager, R A Perlmutter, L E Rosenfeld, et al.
The American Journal of Cardiology|September 1, 1978
Prevalence of right ventricular involvement in inferior wall infarction assessed with myocardial imaging with thallium-201 and technetium-99m pyrophosphateF J Wackers, K I Lie, E B Sokole, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 20, 1998
Nonperfusion applications in nuclear cardiology: report of a task force of the American Society of Nuclear CardiologyE G DePuey, S Port, F J Wackers, et al.
Pageof 16